Next Science set to launch XPerience antimicrobial rinse
Wound care technology developer Next Science will begin commercial sales immediately of its XPerience No Rinse Antimicrobial Solution after it received US Food and Drug Administration approval to market the product. The company’s shares soared 14.5 per cent yesterday on the news to $1.62, with the Sydney company claiming a US$15 billion market potential. Next…
Details